Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290)

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 424.59B KRW in the quarter ending September 30, 2024, with 6.72% growth. This brings the company's revenue in the last twelve months to 1.63T, up 8.23% year-over-year. In the year 2023, Kwang Dong Pharmaceutical had annual revenue of 1.51T with 5.79% growth.

• Revenue (ttm): 1,634.20B
• Revenue Growth: +8.23%
• P/S Ratio: 0.14
• Revenue / Employee: 1.57B
• Employees: 1,042
• Market Cap: 228.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,514.45B	82.91B	5.79%
Dec 31, 2022	1,431.55B	93.36B	6.98%
Dec 31, 2021	1,338.18B	94.41B	7.59%
Dec 31, 2020	1,243.77B	5.51B	0.45%
Dec 31, 2019	1,238.25B	58.03B	4.92%